BMRN
Biomarin Pharmaceutical Inc
Price:  
75.90 
USD
Volume:  
2,859,279.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Biomarin Relative Valuation

-52.6%
Upside

As of 2024-05-24, the Relative Valuation of Biomarin Pharmaceutical Inc (BMRN) is 36.00 USD. This relative valuation is based on P/E multiples. With the latest stock price at 75.90 USD, the upside of Biomarin Pharmaceutical Inc based on Relative Valuation is -52.6%.

The range of the Relative Valuation is 30.50 - 46.09 USD.

Range Selected
Trailing P/E multiples 32.1x - 42.6x 38.2x
Forward P/E multiples 27.9x - 28.3x 28.1x
Fair Price 30.50 - 46.09 36.00
Upside -59.8% - -39.3% -52.6%
75.90 USD
Stock Price
36.00 USD
Fair Price

Biomarin Relative Valuation - Historical P/E Data

Date P/E
2024-05-23 70.15
2024-05-22 70.66
2024-05-21 71.48
2024-05-20 71.22
2024-05-17 71.69
2024-05-16 71.14
2024-05-15 74.31
2024-05-14 73.62
2024-05-13 74.40
2024-05-10 74.89
2024-05-09 75.53
2024-05-08 75.63
2024-05-07 76.33
2024-05-06 75.88
2024-05-03 76.20
2024-05-02 77.45
2024-05-01 77.02
2024-04-30 74.64
2024-04-29 75.91
2024-04-26 74.78
2024-04-25 75.95
2024-04-24 84.29
2024-04-23 85.09
2024-04-22 82.71
2024-04-19 81.92
2024-04-18 83.25
2024-04-17 83.62
2024-04-16 83.99
2024-04-15 84.58
2024-04-12 85.24
2024-04-11 84.53
2024-04-10 83.38
2024-04-09 82.24
2024-04-08 80.67
2024-04-05 80.37
2024-04-04 80.31
2024-04-03 80.21
2024-04-02 80.23
2024-04-01 80.50
2024-03-28 80.73
2024-03-27 81.90
2024-03-26 81.10
2024-03-25 79.97
2024-03-22 78.68
2024-03-21 77.74
2024-03-20 78.34
2024-03-19 78.81
2024-03-18 77.46
2024-03-15 77.52
2024-03-14 78.00